Modified Glass Ionomer Cement with “Remove on Demand” Properties: An In Vitro Study

Objectives: To investigate the influence of different temperatures on the compressive strength of glass ionomer cement (GIC) modified by the addition of silica-coated wax capsules; Material and Methods: Commercially-available GIC was modified by adding 10% silica-coated wax capsules. Test blocks were fabricated from pure cement (control) and modified cement (test), and stored in distilled water (37 °C/23 h). The compressive strength was determined using a universal testing machine under different temperatures (37 °C, 50 °C, and 60 °C). The maximum load to failure was recorded for each group. Fractured surfaces of selected test blocks were observed by scanning electron microscopy (SEM); Results: For the control group, the average compressive strength was 96.8 ± 11.8, 94.3 ± 5.7 and 72.5 ± 5.7 MPa for the temperatures 37 °C, 50 °C and 60 °C respectively. The test group reported compressive strength of 64.8 ± 5.4, 47.1 ± 5.4 and 33.4 ± 3.6 MPa at 37 °C, 50 °C and 60 °C, respectively. This represented a decrease of 28% in compressive strength with the increase in temperature from 37 °C to 50 °C and 45% from the 37 °C to the 60 °C group; Conclusion: GIC modified with 10% silica-coated wax capsules and temperature application show a distinct effect on the compressive strength of GIC. Considerable compressive strength reduction was detected if the temperature was above the melting temperature of the wax core

Retention Forces of Implant-Supported Single Crowns and Fixed Dental Prostheses after Cementation: An In-Vitro Study

The aim of this in vitro study was to investigate three different cements for their suitability to provide semi-permanent cementation, and to compare the retention forces of implant-supported single crowns (SC) and three-unit fixed dental prostheses (FDP) luted with these cements. Twenty-four methacrylate models were supplied with three implants/abutments each to simulate the condition of SCs/FDPs. Cobalt-chromium frameworks were fabricated, sandblasted (Al2O3/50 µm/0.2 MPa) then cemented with glass-ionomer (KTC), polycarboxylate (DUR) or self-adhesive resin cement (RXU). Specimens were stored in a saline-solution (NaCl/37 °C/24 h) or subjected to thermocycling. A universal testing machine and a pull-off device were used to remove the copings. The multi-factor ANOVA showed that the retention force differed significantly among all cements for the SCs after NaCl storage (p < 0.05). Mean retention forces (in Newtons) after NaCl storage were (SCs/FDPs): KTC 170/352, DUR 409/406, RXU 265/426, and after thermocycling (SCs/FDPs): KTC 156/262, DUR 306/380, RXU 494/508. FDPs showed higher retention values in comparison to SCs. For SCs, artificial aging with thermocycling resulted in a significant retention increase for RXU, whereas the retention of KTC and DUR was decreased. Glass ionomer can be used as a semi-permanent cement for both SCs and FDPs. Polycarboxylate cement is considered semi-permanent after one year of aging

Modified Glass Ionomer Cement with "Remove on Demand" Properties: An In Vitro Study

Objectives: To investigate the influence of different temperatures on the compressive strength of glass ionomer cement (GIC) modified by the addition of silica-coated wax capsules; Material and Methods: Commercially-available GIC was modified by adding 10% silica-coated wax capsules. Test blocks were fabricated from pure cement (control) and modified cement (test), and stored in distilled water (37 °C/23 h). The compressive strength was determined using a universal testing machine under different temperatures (37 °C, 50 °C, and 60 °C). The maximum load to failure was recorded for each group. Fractured surfaces of selected test blocks were observed by scanning electron microscopy (SEM); Results: For the control group, the average compressive strength was 96.8 ± 11.8, 94.3 ± 5.7 and 72.5 ± 5.7 MPa for the temperatures 37 °C, 50 °C and 60 °C respectively. The test group reported compressive strength of 64.8 ± 5.4, 47.1 ± 5.4 and 33.4 ± 3.6 MPa at 37 °C, 50 °C and 60 °C, respectively. This represented a decrease of 28% in compressive strength with the increase in temperature from 37 °C to 50 °C and 45% from the 37 °C to the 60 °C group; Conclusion: GIC modified with 10% silica-coated wax capsules and temperature application show a distinct effect on the compressive strength of GIC. Considerable compressive strength reduction was detected if the temperature was above the melting temperature of the wax core

Management of Chronic Atrophic Candidiasis (Denture Stomatitis)&mdash;A Narrative Review

One of the most common oral diseases affecting people wearing dentures is chronic atrophic candidiasis or denture stomatitis (DS). The aim of the paper is to provide an update on the pathogenesis, presentation, and management of DS in general dental practice settings. A comprehensive review of the literature published in the last ten years was undertaken using multiple databases, including PubMed via MEDLINE, EMBASE, and Scopus. The eligible articles were analyzed to identify evidence-based strategies for the management of DS. Despite its multifactorial nature, the leading cause of DS is the development of oral Candida albicans biofilm, which is facilitated by poor oral and denture hygiene, long-term denture wear, ill-fitting dentures, and the porosity of the acrylic resin in the dentures. DS affects between 17 and 75% of the population wearing dentures, with a slight predominance in elderly females. The mucosal denture surfaces and posterior tongue are the common sites of DS, and the affected areas exhibit erythema, the swelling of the palatal mucosa and edema. Oral and denture hygiene protocols, adjusting or re-fabricating poorly adapting dentures, smoking cessation, avoiding nocturnal denture wear, and the administration of topical or systemic antifungals are the mainstay of management. Alternate treatments such as microwave disinfection, phytomedicine, photodynamic therapy, and incorporation of antifungals and nanoparticles into denture resins are being evaluated for the treatment of DS but require further evidence before routine use in clinical practice. In summary, DS is the most common oral inflammatory lesion experienced by denture wearers. Most patients with DS can be managed in general dental practice settings. Effective management by general dental practitioners may be supported by a thorough understanding of the pathogenesis, the recognition of the clinical presentation, and an awareness of contemporary treatment strategies

Management of Chronic Atrophic Candidiasis (Denture Stomatitis)-A Narrative Review.

One of the most common oral diseases affecting people wearing dentures is chronic atrophic candidiasis or denture stomatitis (DS). The aim of the paper is to provide an update on the pathogenesis, presentation, and management of DS in general dental practice settings. A comprehensive review of the literature published in the last ten years was undertaken using multiple databases, including PubMed via MEDLINE, EMBASE, and Scopus. The eligible articles were analyzed to identify evidence-based strategies for the management of DS. Despite its multifactorial nature, the leading cause of DS is the development of oral biofilm, which is facilitated by poor oral and denture hygiene, long-term denture wear, ill-fitting dentures, and the porosity of the acrylic resin in the dentures. DS affects between 17 and 75% of the population wearing dentures, with a slight predominance in elderly females. The mucosal denture surfaces and posterior tongue are the common sites of DS, and the affected areas exhibit erythema, the swelling of the palatal mucosa and edema. Oral and denture hygiene protocols, adjusting or re-fabricating poorly adapting dentures, smoking cessation, avoiding nocturnal denture wear, and the administration of topical or systemic antifungals are the mainstay of management. Alternate treatments such as microwave disinfection, phytomedicine, photodynamic therapy, and incorporation of antifungals and nanoparticles into denture resins are being evaluated for the treatment of DS but require further evidence before routine use in clinical practice. In summary, DS is the most common oral inflammatory lesion experienced by denture wearers. Most patients with DS can be managed in general dental practice settings. Effective management by general dental practitioners may be supported by a thorough understanding of the pathogenesis, the recognition of the clinical presentation, and an awareness of contemporary treatment strategies.Open access funding was provided by the Qatar National Library. The funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication

Management of Chronic Atrophic Candidiasis (Denture Stomatitis)—A Narrative Review

One of the most common oral diseases affecting people wearing dentures is chronic atrophic candidiasis or denture stomatitis (DS). The aim of the paper is to provide an update on the pathogenesis, presentation, and management of DS in general dental practice settings. A comprehensive review of the literature published in the last ten years was undertaken using multiple databases, including PubMed via MEDLINE, EMBASE, and Scopus. The eligible articles were analyzed to identify evidence-based strategies for the management of DS. Despite its multifactorial nature, the leading cause of DS is the development of oral Candida albicans biofilm, which is facilitated by poor oral and denture hygiene, long-term denture wear, ill-fitting dentures, and the porosity of the acrylic resin in the dentures. DS affects between 17 and 75% of the population wearing dentures, with a slight predominance in elderly females. The mucosal denture surfaces and posterior tongue are the common sites of DS, and the affected areas exhibit erythema, the swelling of the palatal mucosa and edema. Oral and denture hygiene protocols, adjusting or re-fabricating poorly adapting dentures, smoking cessation, avoiding nocturnal denture wear, and the administration of topical or systemic antifungals are the mainstay of management. Alternate treatments such as microwave disinfection, phytomedicine, photodynamic therapy, and incorporation of antifungals and nanoparticles into denture resins are being evaluated for the treatment of DS but require further evidence before routine use in clinical practice. In summary, DS is the most common oral inflammatory lesion experienced by denture wearers. Most patients with DS can be managed in general dental practice settings. Effective management by general dental practitioners may be supported by a thorough understanding of the pathogenesis, the recognition of the clinical presentation, and an awareness of contemporary treatment strategies